Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CRBU
$0.38
+0.24%
CRBU
· Caribou Biosciences, Inc.
$0.38
+0.00 (+0.24%)
At close · Nov 13
Return incl. dividend (before tax)
Market Cap
$41.08M
Shares
108.04M
Volume · Nov 12
1.54M
Avg daily vol (3M)
2.72M
All webcasts
Earnings call · FY2023 Q2
Caribou Biosciences, Inc. (CRBU) Q2 2023 Earnings Call
Revenue
$3.75M
-10.4% YoY
Diluted EPS
-$0.48
Net income
-$29.52M
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Jul 13, 2023.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Cash, cash equivalents, and marketable securities
as of June 30, 2023
|
$292.5M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Jul 13, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 17, 2023 · complete as-filed document